Sensitivity, Contact Clinical Trial
Official title:
Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization Under Controlled and Maximised Conditions
This is a clinical study for health care product safety assessment. The research will be conducted with 92 subjects, aged 18 to 59 years. The product will be applied on the right and/or left back of the research participants for 3 consecutive weeks. After 10 days, will have another application of the same product, which will be removed in 48 hours. Medical evaluation will be available throughout the study to assess possible adverse events. The objective of the study is to observe the effects of the application of the product on the skin and prove the absence of irritability and/or allergy.
92 subjects, aged 18 to 59 years, phototypes I to IV (according to Fitzpatrick classification). The patch test will be used to verify the absence of primary and cumulative dermal irritation reactions and sensitization allergic reactions by the investigational products. The products will be applied as they are over semi-occlusive dressings. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04332445 -
Dermatological Assessment of Primary Dermal Irritability Accumulated, Sensitization, Photoallergy and Phototoxicity.
|
N/A | |
Completed |
NCT05508243 -
Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization of Hyaluronic Nasal Spray
|
N/A | |
Completed |
NCT05508230 -
Evaluation of Cutaneous Acceptability and Perceived Effectiveness of a Nasal Spray (Health Care Products)
|
N/A | |
Completed |
NCT03375957 -
Sensitization Study of ATx201 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04250623 -
Dermatological Assessment of Photoallergy and Phototoxicity
|
N/A |